Search
Now showing items 1-2 of 2
Promising novel therapeutic approaches in the management of gastrointestinal stromal tumors
(2017)
Primary and secondary resistance to currently available licensed tyrosine kinase inhibitors poses a real clinical challenge in the management of advanced gastrointestinal stromal tumors. Within the frame of early phase ...
Molecular subtypes of gastrointestinal stromal tumors and their prognostic and therapeutic implications
(2017)
Gastrointestinal stromal tumors (GISTs) are composed of various molecular subtypes, with differing prognostic and predictive relevance. Previously, tumors lacking mutations in the KIT and PDGFRA genes have been designated ...